Table_1_Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasion.docx by Gabriel A. Aguirre (4354087)

“…We also observed that circulating concentrations of RvD5_{n-3 DPA} levels were decreased in peripheral blood of metastatic PDAC patients when compared with those measured in plasma of non-metastatic PDAC patients. …”

Comparative Transcriptome Analysis between the Cytoplasmic Male Sterile Line NJCMS1A and Its Maintainer NJCMS1B in Soybean (<i>Glycine max</i> (L.) Merr.) by Jiajia Li (184267)

“…Three hundred and sixty five differentially expressed genes (DEGs) between NJCMS1A and NJCMS1B were screened by threshold, among which, 339 down-regulated and 26 up-regulated in NJCMS1A compared to in NJCMS1B. …”

Table 5_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

A relational gene network constructed using Pathway Studio 5 from the dataset of significant genes identified by SAM analysis with 70% data filtering (see Table 1). by Valerie W. Hu (223231)

Representative sets of <i>K</i>^<i>trans</i> maps (A) from five different experiments before and after Cilengitide treatment in each set. by Tavarekere N. Nagaraja (501546)

“…Representative sets of <i>v</i>_<i>e</i> maps from the same five experiments before and after Cilengitide treatment in each set are shown in B. …”

Stratigraphic profiles. by Nicole R. Cannarozzi (7901057)

(A) The Arp2/3 complex purified from separated by 2D electrophoresis revealed that Arp2 migrated as five spots and Arp3 as four spots (arrowheads) by Lawrence L. LeClaire (90449)

DataSheet1_Antiviral Efficacy and Safety of Molnupiravir Against Omicron Variant Infection: A Randomized Controlled Clinical Trial.docx by Rongrong Zou (6088067)

“…<p>Background: The rapid worldwide spread of the Omicron variant of SARS-CoV-2 has unleashed a new wave of COVID-19 outbreaks. …”

DataSheet1_Antiviral Efficacy and Safety of Molnupiravir Against Omicron Variant Infection: A Randomized Controlled Clinical Trial.docx by Rongrong Zou (6088067)

“…<p>Background: The rapid worldwide spread of the Omicron variant of SARS-CoV-2 has unleashed a new wave of COVID-19 outbreaks. …”

Colonization of the cervicovaginal space with <i>Gardnerella vaginalis</i> leads to local inflammation and cervical remodeling in pregnant mice by Luz-Jeannette Sierra (134129)

“…CD-1 timed-pregnant mice received a 5X10⁸ CFU/mL intravaginal inoculation of <i>G</i>. …”

Morphology and cell viability in U-87MG, U-251MG, SHSY5Y and N2a cells after treatment with SLCP, BBR and SLCP+BBR. by Panchanan Maiti (1459852)

“…<b>D-E:</b> Cell viability was unaltered in the case of N2a (D) and SH-SY5Y cells after 24-h of SLCP and or BBR, although co-treatment caused a 40% increase in cell death in SH-SY5Y cells (<b>E</b>). …”

Table 1_Targeting APE1/Ref-1 to alleviate formalin-induced pain and spinal neuro-inflammation in rats: a promising therapeutic approach.xlsx by Eman Elgendy (21811052)

“…Notably, E3330 treatment maintained normal APE1/Ref-1 levels and promoted a more organized mitochondrial structure. Administration of E3330 correlated with increased dopamine levels, a decrease in the mRNA expression of dopamine receptors DRD1 and DRD5, and a restoration of DRD2 expression in the ipsilateral spinal cords. …”

Image_1_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.tif by Mengting Chen (1419172)

“…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”

Image_2_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.tif by Mengting Chen (1419172)

“…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”

Data_Sheet_3_MiR-409-5p as a Regulator of Neurite Growth Is Down Regulated in APP/PS1 Murine Model of Alzheimer’s Disease.pdf by Jing Guo (102972)

“…We now report that miR-409-5p impairs neurite outgrowth, decreases neuronal viability, and accelerates the progression of Aβ₁_–₄₂-induced pathologies. …”

Data_Sheet_1_MiR-409-5p as a Regulator of Neurite Growth Is Down Regulated in APP/PS1 Murine Model of Alzheimer’s Disease.pdf by Jing Guo (102972)

“…We now report that miR-409-5p impairs neurite outgrowth, decreases neuronal viability, and accelerates the progression of Aβ₁_–₄₂-induced pathologies. …”

Data_Sheet_2_MiR-409-5p as a Regulator of Neurite Growth Is Down Regulated in APP/PS1 Murine Model of Alzheimer’s Disease.pdf by Jing Guo (102972)

“…We now report that miR-409-5p impairs neurite outgrowth, decreases neuronal viability, and accelerates the progression of Aβ₁_–₄₂-induced pathologies. …”

DataSheet_1_Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.pdf by Hoa Thi My Vo (4556779)

“…Asymptomatic infection resulted in decreased antibody-dependent cellular cytotoxicity (ADCC) and frequency of SARS-CoV-2-specific CD4⁺ T cells at late convalescence. …”

Table_5_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOCX by Yaqi Li (2936265)

DataSheet_1_Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss.docx by Eszter Lilla Tóth (17999557)

“…</p>Case<p>Here we report the case of a 28-year-old SARS-CoV-2 infected pregnant patient, admitted to our hospital at 28 weeks of gestation with intrauterine fetal loss. …”